Global Cancer Testing/Screening Market Size, Status and Forecast 2018-2025

Date: Oct 15 2018
|
QYRESEARCH
|
Number of Pages: 90
|
Alternate Text Alternate Text Alternate Text Alternate Text

Screening means checking your body for cancer before you have symptoms.
In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer.
In 2017, the global Cancer Testing/Screening market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global Cancer Testing/Screening status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Testing/Screening development in United States, Europe and China.

The key players covered in this study
Dias Orin
Epigenetics
Techlab
Positive Bioscience
Genextropy
M Genomics
20/20 GeneSystems
AB SCIEX
Abbott Laboratories

Market segment by Type, the product can be split into
Lung Cancer
Blood Cancer
Bone Cancer
Gall Bladder Cancer
Others

Market segment by Application, split into
Hospitals and Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cancer Testing/Screening status, future forecast, growth opportunity, key market and key players.
To present the Cancer Testing/Screening development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Testing/Screening are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents
1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
           1.4.1 Global Cancer Testing/Screening Market Size Growth Rate by Type (2013-2025)
           1.4.2 Lung Cancer
           1.4.3 Blood Cancer
           1.4.4 Bone Cancer
           1.4.5 Gall Bladder Cancer
           1.4.6 Others
    1.5 Market by Application
           1.5.1 Global Cancer Testing/Screening Market Share by Application (2013-2025)
           1.5.2 Hospitals and Clinics
           1.5.3 Others
    1.6 Study Objectives
    1.7 Years Considered
2 Global Growth Trends
    2.1 Cancer Testing/Screening Market Size
    2.2 Cancer Testing/Screening Growth Trends by Regions
           2.2.1 Cancer Testing/Screening Market Size by Regions (2013-2025)
           2.2.2 Cancer Testing/Screening Market Share by Regions (2013-2018)
    2.3 Industry Trends
           2.3.1 Market Top Trends
           2.3.2 Market Drivers
           2.3.3 Market Opportunities
3 Market Share by Key Players
    3.1 Cancer Testing/Screening Market Size by Manufacturers
           3.1.1 Global Cancer Testing/Screening Revenue by Manufacturers (2013-2018)
           3.1.2 Global Cancer Testing/Screening Revenue Market Share by Manufacturers (2013-2018)
           3.1.3 Global Cancer Testing/Screening Market Concentration Ratio (CR5 and HHI)
    3.2 Cancer Testing/Screening Key Players Head office and Area Served
    3.3 Key Players Cancer Testing/Screening Product/Solution/Service
    3.4 Date of Enter into Cancer Testing/Screening Market
    3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
    4.1 Global Cancer Testing/Screening Market Size by Type (2013-2018)
    4.2 Global Cancer Testing/Screening Market Size by Application (2013-2018)
5 United States
    5.1 United States Cancer Testing/Screening Market Size (2013-2018)
    5.2 Cancer Testing/Screening Key Players in United States
    5.3 United States Cancer Testing/Screening Market Size by Type
    5.4 United States Cancer Testing/Screening Market Size by Application
6 Europe
    6.1 Europe Cancer Testing/Screening Market Size (2013-2018)
    6.2 Cancer Testing/Screening Key Players in Europe
    6.3 Europe Cancer Testing/Screening Market Size by Type
    6.4 Europe Cancer Testing/Screening Market Size by Application
7 China
    7.1 China Cancer Testing/Screening Market Size (2013-2018)
    7.2 Cancer Testing/Screening Key Players in China
    7.3 China Cancer Testing/Screening Market Size by Type
    7.4 China Cancer Testing/Screening Market Size by Application
8 Japan
    8.1 Japan Cancer Testing/Screening Market Size (2013-2018)
    8.2 Cancer Testing/Screening Key Players in Japan
    8.3 Japan Cancer Testing/Screening Market Size by Type
    8.4 Japan Cancer Testing/Screening Market Size by Application
9 Southeast Asia
    9.1 Southeast Asia Cancer Testing/Screening Market Size (2013-2018)
    9.2 Cancer Testing/Screening Key Players in Southeast Asia
    9.3 Southeast Asia Cancer Testing/Screening Market Size by Type
    9.4 Southeast Asia Cancer Testing/Screening Market Size by Application
10 India
    10.1 India Cancer Testing/Screening Market Size (2013-2018)
    10.2 Cancer Testing/Screening Key Players in India
    10.3 India Cancer Testing/Screening Market Size by Type
    10.4 India Cancer Testing/Screening Market Size by Application
11 Central & South America
    11.1 Central & South America Cancer Testing/Screening Market Size (2013-2018)
    11.2 Cancer Testing/Screening Key Players in Central & South America
    11.3 Central & South America Cancer Testing/Screening Market Size by Type
    11.4 Central & South America Cancer Testing/Screening Market Size by Application
12 International Players Profiles
    12.1 Dias Orin
           12.1.1 Dias Orin Company Details
           12.1.2 Company Description and Business Overview
           12.1.3 Cancer Testing/Screening Introduction
           12.1.4 Dias Orin Revenue in Cancer Testing/Screening Business (2013-2018)
           12.1.5 Dias Orin Recent Development
    12.2 Epigenetics
           12.2.1 Epigenetics Company Details
           12.2.2 Company Description and Business Overview
           12.2.3 Cancer Testing/Screening Introduction
           12.2.4 Epigenetics Revenue in Cancer Testing/Screening Business (2013-2018)
           12.2.5 Epigenetics Recent Development
    12.3 Techlab
           12.3.1 Techlab Company Details
           12.3.2 Company Description and Business Overview
           12.3.3 Cancer Testing/Screening Introduction
           12.3.4 Techlab Revenue in Cancer Testing/Screening Business (2013-2018)
           12.3.5 Techlab Recent Development
    12.4 Positive Bioscience
           12.4.1 Positive Bioscience Company Details
           12.4.2 Company Description and Business Overview
           12.4.3 Cancer Testing/Screening Introduction
           12.4.4 Positive Bioscience Revenue in Cancer Testing/Screening Business (2013-2018)
           12.4.5 Positive Bioscience Recent Development
    12.5 Genextropy
           12.5.1 Genextropy Company Details
           12.5.2 Company Description and Business Overview
           12.5.3 Cancer Testing/Screening Introduction
           12.5.4 Genextropy Revenue in Cancer Testing/Screening Business (2013-2018)
           12.5.5 Genextropy Recent Development
    12.6 M Genomics
           12.6.1 M Genomics Company Details
           12.6.2 Company Description and Business Overview
           12.6.3 Cancer Testing/Screening Introduction
           12.6.4 M Genomics Revenue in Cancer Testing/Screening Business (2013-2018)
           12.6.5 M Genomics Recent Development
    12.7 20/20 GeneSystems
           12.7.1 20/20 GeneSystems Company Details
           12.7.2 Company Description and Business Overview
           12.7.3 Cancer Testing/Screening Introduction
           12.7.4 20/20 GeneSystems Revenue in Cancer Testing/Screening Business (2013-2018)
           12.7.5 20/20 GeneSystems Recent Development
    12.8 AB SCIEX
           12.8.1 AB SCIEX Company Details
           12.8.2 Company Description and Business Overview
           12.8.3 Cancer Testing/Screening Introduction
           12.8.4 AB SCIEX Revenue in Cancer Testing/Screening Business (2013-2018)
           12.8.5 AB SCIEX Recent Development
    12.9 Abbott Laboratories
           12.9.1 Abbott Laboratories Company Details
           12.9.2 Company Description and Business Overview
           12.9.3 Cancer Testing/Screening Introduction
           12.9.4 Abbott Laboratories Revenue in Cancer Testing/Screening Business (2013-2018)
           12.9.5 Abbott Laboratories Recent Development
13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
    15.1 Research Methodology
           15.1.1 Methodology/Research Approach
                 15.1.1.1 Research Programs/Design
                 15.1.1.2 Market Size Estimation
                 12.1.1.3 Market Breakdown and Data Triangulation
           15.1.2 Data Source
                 15.1.2.1 Secondary Sources
                 15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details

List of Tables and Figures
Table Cancer Testing/Screening Key Market Segments
Table Key Players Cancer Testing/Screening Covered
Table Global Cancer Testing/Screening Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Cancer Testing/Screening Market Size Market Share by Type 2013-2025
Figure Lung Cancer Figures
Table Key Players of Lung Cancer
Figure Blood Cancer Figures
Table Key Players of Blood Cancer
Figure Bone Cancer Figures
Table Key Players of Bone Cancer
Figure Gall Bladder Cancer Figures
Table Key Players of Gall Bladder Cancer
Figure Others Figures
Table Key Players of Others
Table Global Cancer Testing/Screening Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospitals and Clinics Case Studies
Figure Others Case Studies
Figure Cancer Testing/Screening Report Years Considered
Table Global Cancer Testing/Screening Market Size 2013-2025 (Million US$)
Figure Global Cancer Testing/Screening Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Cancer Testing/Screening Market Size by Regions 2013-2025 (Million US$)
Table Global Cancer Testing/Screening Market Size by Regions 2013-2018 (Million US$)
Table Global Cancer Testing/Screening Market Share by Regions 2013-2018
Figure Global Cancer Testing/Screening Market Share by Regions 2013-2018
Figure Global Cancer Testing/Screening Market Share by Regions 2018
Table Market Top Trends
Table Global Cancer Testing/Screening Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Cancer Testing/Screening Market Share by Manufacturers (2013-2018)
Figure Global Cancer Testing/Screening Market Share by Manufacturers in 2018
Table Global Cancer Testing/Screening Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cancer Testing/Screening Product/Solution/Service
Table Date of Enter into Cancer Testing/Screening Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cancer Testing/Screening Market Size by Type (2013-2018) (Million US$)
Table Global Cancer Testing/Screening Market Size Share by Type (2013-2018)
Figure Global Cancer Testing/Screening Market Size Market Share by Type (2013-2018)
Table Global Cancer Testing/Screening Market Size by Application (2013-2018) (Million US$)
Table Global Cancer Testing/Screening Market Size Share by Application (2013-2018)
Figure Global Cancer Testing/Screening Market Size Market Share by Application (2013-2018)
Figure Global Cancer Testing/Screening Revenue Market Share by Application in 2017
Figure United States Cancer Testing/Screening Market Size 2013-2018 (Million US$)
Table United States Key Players Cancer Testing/Screening Revenue (2017-2018) (Million US$)
Table United States Key Players Cancer Testing/Screening Market Share (2017-2018)
Table United States Cancer Testing/Screening Market Size by Type (2013-2018) (Million US$)
Table United States Cancer Testing/Screening Market Share by Type (2013-2018)
Table United States Cancer Testing/Screening Market Size by Application (2013-2018) (Million US$)
Table United States Cancer Testing/Screening Market Share by Application (2013-2018)
Figure Europe Cancer Testing/Screening Market Size 2013-2018 (Million US$)
Table Europe Key Players Cancer Testing/Screening Revenue (2017-2018) (Million US$)
Table Europe Key Players Cancer Testing/Screening Market Share (2017-2018)
Table Europe Cancer Testing/Screening Market Size by Type (2013-2018) (Million US$)
Table Europe Cancer Testing/Screening Market Share by Type (2013-2018)
Table Europe Cancer Testing/Screening Market Size by Application (2013-2018) (Million US$)
Table Europe Cancer Testing/Screening Market Share by Application (2013-2018)
Figure China Cancer Testing/Screening Market Size 2013-2018 (Million US$)
Table China Key Players Cancer Testing/Screening Revenue (2017-2018) (Million US$)
Table China Key Players Cancer Testing/Screening Market Share (2017-2018)
Table China Cancer Testing/Screening Market Size by Type (2013-2018) (Million US$)
Table China Cancer Testing/Screening Market Share by Type (2013-2018)
Table China Cancer Testing/Screening Market Size by Application (2013-2018) (Million US$)
Table China Cancer Testing/Screening Market Share by Application (2013-2018)
Figure Japan Cancer Testing/Screening Market Size 2013-2018 (Million US$)
Table Japan Key Players Cancer Testing/Screening Revenue (2017-2018) (Million US$)
Table Japan Key Players Cancer Testing/Screening Market Share (2017-2018)
Table Japan Cancer Testing/Screening Market Size by Type (2013-2018) (Million US$)
Table Japan Cancer Testing/Screening Market Share by Type (2013-2018)
Table Japan Cancer Testing/Screening Market Size by Application (2013-2018) (Million US$)
Table Japan Cancer Testing/Screening Market Share by Application (2013-2018)
Figure Southeast Asia Cancer Testing/Screening Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Cancer Testing/Screening Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Cancer Testing/Screening Market Share (2017-2018)
Table Southeast Asia Cancer Testing/Screening Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Cancer Testing/Screening Market Share by Type (2013-2018)
Table Southeast Asia Cancer Testing/Screening Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Cancer Testing/Screening Market Share by Application (2013-2018)
Figure India Cancer Testing/Screening Market Size 2013-2018 (Million US$)
Table India Key Players Cancer Testing/Screening Revenue (2017-2018) (Million US$)
Table India Key Players Cancer Testing/Screening Market Share (2017-2018)
Table India Cancer Testing/Screening Market Size by Type (2013-2018) (Million US$)
Table India Cancer Testing/Screening Market Share by Type (2013-2018)
Table India Cancer Testing/Screening Market Size by Application (2013-2018) (Million US$)
Table India Cancer Testing/Screening Market Share by Application (2013-2018)
Figure Central & South America Cancer Testing/Screening Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Cancer Testing/Screening Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Cancer Testing/Screening Market Share (2017-2018)
Table Central & South America Cancer Testing/Screening Market Size by Type (2013-2018) (Million US$)
Table Central & South America Cancer Testing/Screening Market Share by Type (2013-2018)
Table Central & South America Cancer Testing/Screening Market Size by Application (2013-2018) (Million US$)
Table Central & South America Cancer Testing/Screening Market Share by Application (2013-2018)
Table Dias Orin Company Details
Table Dias Orin Revenue in Cancer Testing/Screening Business (2013-2018) (Million US$)
Figure Dias Orin Revenue Growth Rate in Cancer Testing/Screening Business (2013-2018)
Table Dias Orin Recent Development
Table Epigenetics Company Details
Table Epigenetics Revenue in Cancer Testing/Screening Business (2013-2018)(Million US$)
Figure Epigenetics Revenue Growth Rate in Cancer Testing/Screening Business (2013-2018)
Table Epigenetics Recent Development
Table Techlab Company Details
Table Techlab Revenue in Cancer Testing/Screening Business (2013-2018)(Million US$)
Figure Techlab Revenue Growth Rate in Cancer Testing/Screening Business (2013-2018)
Table Techlab Recent Development
Table Positive Bioscience Company Details
Table Positive Bioscience Revenue in Cancer Testing/Screening Business (2013-2018)(Million US$)
Figure Positive Bioscience Revenue Growth Rate in Cancer Testing/Screening Business (2013-2018)
Table Positive Bioscience Recent Development
Table Genextropy Company Details
Table Genextropy Revenue in Cancer Testing/Screening Business (2013-2018)(Million US$)
Figure Genextropy Revenue Growth Rate in Cancer Testing/Screening Business (2013-2018)
Table Genextropy Recent Development
Table M Genomics Company Details
Table M Genomics Revenue in Cancer Testing/Screening Business (2013-2018)(Million US$)
Figure M Genomics Revenue Growth Rate in Cancer Testing/Screening Business (2013-2018)
Table M Genomics Recent Development
Table 20/20 GeneSystems Company Details
Table 20/20 GeneSystems Revenue in Cancer Testing/Screening Business (2013-2018)(Million US$)
Figure 20/20 GeneSystems Revenue Growth Rate in Cancer Testing/Screening Business (2013-2018)
Table 20/20 GeneSystems Recent Development
Table AB SCIEX Company Details
Table AB SCIEX Revenue in Cancer Testing/Screening Business (2013-2018)(Million US$)
Figure AB SCIEX Revenue Growth Rate in Cancer Testing/Screening Business (2013-2018)
Table AB SCIEX Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Cancer Testing/Screening Business (2013-2018)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Cancer Testing/Screening Business (2013-2018)
Table Abbott Laboratories Recent Development
Table Global Cancer Testing/Screening Market Size by Regions (Million US$) 2018-2025
Figure Global Cancer Testing/Screening Market Size Share by Regions (2018-2025)
Figure Global Cancer Testing/Screening Market Size Share by Regions in 2025
Figure United States Cancer Testing/Screening Market Size Forecast (2018-2025)(Million USD)
Figure Europe Cancer Testing/Screening Market Size Forecast (2018-2025)(Million USD)
Figure China Cancer Testing/Screening Market Size Forecast (2018-2025)(Million USD)
Figure Japan Cancer Testing/Screening Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Cancer Testing/Screening Market Size Forecast (2018-2025)(Million USD)
Figure India Cancer Testing/Screening Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Cancer Testing/Screening Market Size Forecast (2018-2025)(Million USD)
Table Global Cancer Testing/Screening Market Size by Product (2018-2025) (Million US$)
Figure Global Cancer Testing/Screening Market Size by Product (2018-2025)
Figure Global Cancer Testing/Screening Market Size by Product in 2025
Table Global Cancer Testing/Screening Market Size by Application (2018-2025) (Million US$)
Figure Global Cancer Testing/Screening Market Size by Application (2018-2025)
Figure Global Cancer Testing/Screening Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
+
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.